Top

Once-daily treatment for heartburn and other symptoms of gastroesophageal reflux disease (GERD), and for erosive esophagitis due to acid-mediated GERD.

*Subject to eligibility rules; restrictions apply. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D and Medicare Advantage), TriCare, CHAMPUS, or any other local, state or federal healthcare programs, including state prescription drug assistance programs and the La Reforma de Salud program in Puerto Rico.

The PRILOSEC® Packets Savings Card program is not valid in the state of Vermont and the PRILOSEC® Packets Savings Card is not eligible for redemption by patients in Vermont.

Indications for PRILOSEC® Packets for delayed-release oral suspension:

  • PRILOSEC is indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD) for up to 4 weeks in adults and children 1 year and older.
  • In infants 1 month to less than 1 year, PRILOSEC is indicated for the short-term treatment (up to 6 weeks) of erosive esophagitis (EE) due to acid-mediated GERD.
  • PRILOSEC is indicated for the treatment of symptomatic gastroesophageal reflux disease (GERD) for up to 4 weeks in adults and children 1 year and older.

Reference: PRILOSEC [package insert]. Zug, Switzerland: Covis Pharma; 2017.